Activity: Talk or presentation types › Invited talk
Description
Series of meetings establishing basis for engagement with AstraZeneca and funding organizations regarding development of a CXCR2 inhibitor trial in castrate-resistant prostate cancer (with Prof Johann de Bono and Prof Alessandro Alimonti)